Curriculum Vitae
Mafalda de Castro Ascensão Marques Videira
Identification
Personal identification
- Full name
- Mafalda de Castro Ascensão Marques Videira
Citation names
- Videira, Mafalda
- Mafalda Ascensão Videira
- Mafalda A Videira
Author identifiers
- Ciência ID
- BE12-7241-1069
- ORCID iD
- 0000-0003-4184-3963
- Researcher Id
- J-7563-2012
- Scopus Author Id
- 24286617000
Languages
| Language | Speaking | Reading | Writing | Listening | Peer-review |
|---|---|---|---|---|---|
| English | Advanced (C1) | Advanced (C1) | Advanced (C1) | Advanced (C1) | |
| English | Advanced (C1) | Advanced (C1) | Advanced (C1) | Advanced (C1) | |
| Spanish; Castilian | Intermediate (B1) | Intermediate (B1) | Beginner (A1) | Intermediate (B1) | |
| French | Beginner (A1) | Intermediate (B1) | Beginner (A1) | Beginner (A1) |
Education
| Degree | Classification | |
|---|---|---|
|
2022/05/31 - 2022/06/01
Concluded
|
Ciências Farmacêuticas (Título de Agregado)
Major in Tecnologia Farmacêutica
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
Distinção e louvor |
|
2013/10 - 2014/04
Concluded
|
Basic Training in European Patent Law (Curso de Especialização Tecnológica)
Major in Direito Industrial
Universite de Strasbourg Centre d'Etudes Internationales de la Propriete Intellectuelle, France
|
N/A |
|
1998/01 - 2008/07/28
Concluded
|
Farmácia (Doutoramento)
Major in Especialidade: Tecnologia Farmacêutica
Universidade de Lisboa, Portugal
"Nanopartículas Lipídicas Como Sistemas Transportadores de Fármacos para Administração Pulmonar" (THESIS/DISSERTATION)
|
cum laude |
|
1994/01
Concluded
|
Masters’ Degree in Biotechnology and Biochemical Engineering (Mestrado)
Universidade de Lisboa Instituto Superior Técnico, Portugal
"Liquid-Liquid Extraction of Clavulanic Acid by using a system of two Aqueous Phases, PEG-Salt" (THESIS/DISSERTATION)
|
Bom |
|
1990/07/05
Concluded
|
Pharmaceutical Sciences University Course – Option: Industrial Pharmacy, in the Faculdade de Farmácia, Universidade de Lisboa
(FFUL) (Licenciatura)
Universidade de Lisboa Faculdade de Farmácia, Portugal
"Qualificação da produção industrial de medicamentos" (THESIS/DISSERTATION)
|
14 |
Affiliation
Teaching in Higher Education
| Category Host institution |
Employer | |
|---|---|---|
| 1998 - Current | Assistant Professor (University Teacher) | Universidade de Lisboa, Portugal |
| Universidade de Lisboa Faculdade de Farmácia, Portugal | ||
| 2014 - 2017 | Assistant Professor (University Teacher) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
| Universidade de Lisboa Faculdade de Farmácia, Portugal (...) |
Projects
Grant
| Designation | Funders | |
|---|---|---|
| 2012/03 - 2015/09 | TherMelVac- dendritic cell-targeted peptide vaccine against melanoma by ligand-modified nanoparticles | Fundação para a Ciência e a Tecnologia |
| 2012/02 - 2015/09 | siRNA incorporation in a lipid/micelle-based nanocarrier as a strategy to restore E-cadherin expression and eradicate advanced breast cancer metastatic phenotype | Fundação para a Ciência e a Tecnologia |
| 2011/01 - 2014/06 | Pre-clinical assays of a GAPDH-based vaccine against Group B Streptococcus infection | Fundação para a Ciência e a Tecnologia |
| 2009 - 2011 | Advancing the field of drug delivery - combined targeted treatments against human breast cancer and human leukemia
NANO/NMed-AT/0042/2007
Research Fellow
|
Concluded
|
| 1997 - 2002 | Transporting systems for imageology diagnosis and therapy connected to the lymphatic circulation of the lung
2/2.1/SAU/1305/95
Research Fellow
|
Concluded
|
Contract
| Designation | Funders | |
|---|---|---|
| 2018/09/01 - 2021/08/31 | Detect, prevent, eradicate: a multi-step strategy to abrogate brain metastasization of breast cancer
PTDC/MED-ONC/29402/2017
Co-Investigador Responsável
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
| 2018/03/01 - 2021/03/31 | TARGET_Cancer -Study of the inhibition of human thioredoxin system
PTDC/MED-FAR/31136/2017
Researcher
|
Ongoing
|
| 2017/03 - 2020/09 | NANOGLIO-Nanotechnology based immunotherapy for glioblastoma
Principal investigator
|
EU 7th Framework Programme-EURONANOMED Fundação para a Ciência e a Tecnologia Ongoing
|
| 2017/09/01 - 2019/09/30 | Brain metastasization of breast cancer: from phenotype to pathways and signalling
Proc. 441.00 HUNGRIA
Researcher
|
Concluded
|
| 2016/03/01 - 2019/03/31 | Traget4Cancer - (Nano) systems with active targeting to sensitize colorectal cancer stem cells to anti-tumoral treatment
ENMed/0009/2015
Principal investigator
|
Concluded
|
| 2013/01 - 2017/09 | Exploring the Mycobacteriophage lysis proteins to destroy the Mycobacteria Cell envelope
Researcher
|
Fundação para a Ciência e a Tecnologia
Concluded
|
| 2012/03 - 2015/09 | TherMelVac- dendritic cell-targeted peptide vaccine against melanoma by ligand-modified nanoparticles
Researcher
|
Fundação para a Ciência e a Tecnologia
Concluded
|
| 2012/02 - 2015/09 | siRNA incorporation in a lipid/micelle-based nanocarrier as a strategy to restore E-cadherin expression and eradicate advanced
breast cancer metastatic phenotype
Principal investigator
|
Fundação para a Ciência e a Tecnologia
Concluded
|
| 2011/01 - 2014/06 | Pre-clinical assays of a GAPDH-based vaccine against Group B Streptococcus infection
Post-doc
|
Fundação para a Ciência e a Tecnologia
Concluded
|
| 2010/03 - 2013/06 | NanoStem - "Targeting combined therapy to cancer stem cells" ENMED/NMed/0001/2009
ENMED/NMed/0001/2009
Researcher
|
Concluded
|
| 2010 - 2012 | microRNAs and drug-nanoparticles targeting SPARC: tools for detection and fighting-off metastatic melanoma
PEst-OE/SAU/UI4013/2011
Researcher
|
Concluded
|
Other
| Designation | Funders | |
|---|---|---|
| 2015/10/13 - 2019/10/02 | COST Action MP1404 "SimInhale"
Portuguese Member Committee
European Cooperation in Science and Technology, Belgium
|
Concluded
|
Outputs
Publications
| Book |
|
| Book chapter |
|
| Journal article |
|
| Thesis / Dissertation |
|
Intellectual property
| Patent |
|
Other
| Other output |
|
Activities
Oral presentation
| Presentation title | Event name Host (Event location) |
|
|---|---|---|
| 2021/03/19 | Nanomedicines as a highway to brain | Models of the Blood-Brain Barrier - Scientific Tools to Target the Brain
FFUL (Lisboa, Portugal)
|
Supervision
| Thesis Title Role |
Degree Subject (Type) Institution / Organization |
|
|---|---|---|
| 2019 - Current | Combinatory strategy for Non-Small Cell Lung Cancer: cleaning the primary compartment while eradicating brain metastasis
Supervisor
|
Doutoramento em Farmácia (PhD) |
| 2019 - Current | Decoding the “influencers’ talk show” between lung cancer cells and their host environment (Brain)
Supervisor
|
Doutoramento em Farmácia, Tecnologia Farmacêutica (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
| 2018/03 - 2019/11 | Micelas contendo Paclitaxel para uma terapêutica direcionada ao cancro colo rectal por administração rectal.
Co-supervisor
|
Mestrado em Tecnologia Farmacêutica (Master)
Universidade do Porto Faculdade de Farmácia, Portugal
|
| 2017/09 - 2018/12 | Circulating microRNAs as Biomarkers for Breast Cancer Brain Metastasis
Co-supervisor
|
Biociências Farmacêuticas (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
| 2016 - 2018 | Polymeric Micelles to improve Salinomycine delivery to cancer cells
Co-supervisor
|
Mestrado em Biotecnologia Farmacêutica (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
|
| 2012 - 2018 | Akt2 siRNA-nanoparticulate system as a new tool to restoration of E-cadherin and eradicate tumour metastic phenotype
Supervisor
|
iMed.UL- Research Institute for Medicines and Pharmaceutical Sciences (PhD) |
| 2016 - 2017 | • . Master’s Thesis: “Circulating microRNAs as Biomarkers for Breast Cancer Brain Metastasis”, . September 2017-December 2018.
Co-Supervisor.
Co-supervisor
|
Master in Pharmaceutical Biosiences (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
| 2012 - 2015 | Antitumor immunity induced by a new breast carcinoma combination adjuvant: a mechanistic approach
Co-supervisor
|
iMed.UL- Research Institute for Medicines and Pharmaceutical Sciences (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
| 2011 - 2014 | Glucose-sensitive nanocarriers for controlled pulmonary administration of insulin"
Co-supervisor
|
Institute for Medicines and Pharmaceutical Sciences) (PhD) |
| 2010 - 2014 | Design of a therapeutic melanoma vaccine candidate: delivery strategies of a peptide antigen to dendritic cells
Co-supervisor
|
Nanomedicine & Drug Delivery Systems Group (iMed.UL- Research Institute for Medicines and Pharmaceutical Sciences) (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
Event organisation
| Event name Type of event (Role) |
Institution / Organization | |
|---|---|---|
| 2016/02 - 2016/02 | COST Action consortium - MC and WGs meeting on 22-23 February Venue: FFUL, February. Member of the Organising Committee. (2013/02 - 2013/02)
Symposium (Member of the Scientific Committee)
|
Universidade de Lisboa Faculdade de Farmácia, Portugal European Cooperation in Science and Technology, Belgium |
| 2013/02 - 2013/02 | Chair of the Organizing Committee of the academic conference on “Propriedade Industrial (Intellectual property)” which gathered
over 200 participants from diverse disciplines. With the presence of the Ministry of Justice. Venue: FFUL (2013/02 - 2013/02)
Conference (Member of the Organising Committee)
|
Associação Portuguesa de Direito Intelectual, Portugal Universidade de Lisboa Faculdade de Farmácia, Portugal |
| 2007 - 2012 | 3th to 7th Annual Bioethics post-graduate course APDI. Member of the Organising and Scientific program. (2007 - 2012) | Associação Portuguesa de Direito Intelectual, Portugal Centro de Engenharia e Tecnologia Naval e Oceanica, Portugal |
Event participation
| Activity description Type of event |
Event name Institution / Organization |
|
|---|---|---|
| 2014 - 2015 | Entrepreneurship training at COHITECH, ISCTE-IUL MIT Portugal Competition
a four-month training program in technology commercialization,
destined to researchers from Portuguese R&D Institutions, who wish to:
• evaluate the commercial viability of the innovative technologies they have
developed;
• gain technology commercialization and entrepreneurial skills.
2NanoPlex: A multiplexed nanotherapeutic system for a novel combined therapeutic approach for lung cancer treatment.2
Call
|
COTEC Portugal - Associação Empresarial para a Inovação |
| 2007 - 2008 | Cohitec, Entrepreneurship program
four-month training program in technology commercialization, destined to researchers from Portuguese R&D Institutions,
"Pulmocure: Safe Target in Healthcare"
Call
|
COTEC Portugal - Associação Empresarial para a Inovação |
Jury of academic degree
| Topic Role |
Candidate name (Type of degree) Institution / Organization |
|
|---|---|---|
| 2018/12 | Radiolabelling and preclinical evaluation of nanoparticles as drug delivery systems: Application to infectious pulmonary diseases.
December 2018 Donostia, Spain
(Thesis) Arguer
|
Unai Cossío Arrieta (PhD)
Radiochemistry and Nuclear Imaging Group, CIC biomaGUNE, Spain
|
| 2011/01 | Exploring MEK5/ERK5 Signalling and miRNAs as Therapeutic Strategies in Colon Cancer.
(Thesis) Arguer
|
André Gonçalo do Espírito Santo Simões (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal |
Association member
| Society Organization name | Role | |
|---|---|---|
| 2015 - 2019/10 | COST Action MP1404, “SimInahle” | Membro |
Committee member
| Activity description Role |
Institution / Organization | |
|---|---|---|
| 2014 - 2017 | Member of the Organizing and Scientific program in the 1th Curso pós-graduado em Bioética created by the Pharmaceutical, Medical
and Law schools from Universidade de Lisboa, which brings together professionals from different areas.
Coordinator
|
Universidade de Lisboa Faculdade de Farmácia, Portugal |
| 2011 - 2017 | Comissão de Ética para uso Humano, Faculdade de Farmácia da Universidade de Lisboa
President / Vice-president
|
Universidade de Lisboa Faculdade de Farmácia, Portugal |
| 2010 - 2013 | Member of board coordination for the Bioethics post-graduation organisation at the Portuguese Association of Intellectual
Property (APDI), since
Coordinator
|
Universidade de Lisboa Faculdade de Farmácia, Portugal Universidade de Lisboa Faculdade de Direito, Portugal Associação Portuguesa de Direito Intelectual, Portugal |
Consulting
| Activity description | Institution / Organization | |
|---|---|---|
| 2011/01 - Current | Advisor in IP diligence procedures as scientific expert |
Course / Discipline taught
| Academic session | Degree Subject (Type) | Institution / Organization | |
|---|---|---|---|
| 2014 - Current | Organização Industrial e Patentes | RAMPS (Postgraduate Certificate) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
| 2014 - 2017 | Bioética/Bioethics | Bioética (Especialização pós-licenciatura) | Universidade de Lisboa Faculdade de Farmácia, Portugal Universidade de Lisboa Faculdade de Direito, Portugal Universidade de Lisboa Faculdade de Medicina, Portugal |
| 2010 - 2013 | Bioethics | Bioethics post-graduation (Postgraduate Certificate) | Universidade de Lisboa Faculdade de Direito, Portugal |
| 2008/01 - 2011 | Direito da Medicine - 3th to 5th Summer school Workshops in Bioethics, APDI, Member of the Organising and Scientific program. | Summer school Workshops in Bioethics (Pós-Graduação) | Associação Portuguesa de Direito Intelectual, Portugal |
Evaluation committee
| Activity description Role |
Institution / Organization | Funding entity | |
|---|---|---|---|
| 2009/04 - Current | Comissão de avaliação de Medicamentos Veterinários GAMV-
Evaluator
|
Direcção-Geral de Alimentação e Veterinária, Portugal | Ministério da Agricultura Florestas e Desenvolvimento Rural |
| 2014/05/05 - 2021/09 | Member of Ethical Committee CAML, Comissão de Ética do Centro Académico de Medicina de Lisboa
(CHLN/FMUL/IMM)
Evaluator
|
Centro Hospitalar Universitário Lisboa Norte EPE, Portugal | |
| 2011/05/27 - 2018/11 | Esta Comissão de Ética reger-se-á essencialmente pelo regime jurídico aplicável à realização de ensaios clínicos com medicamentos
de uso humano, aprovado pela Lei nº 46/2004 de 19 de Agosto, enquanto transposição para a ordem jurídica nacional da Directiva
Comunitária nº 2001/20/CE de 4 Abril, bem como pelo Decreto-Lei nº 102/07 de 2 de Abril, enquanto transposição da Directriz
Comunitária n.º 2005/28/CE da Comissão, de 8 de Abril, e ainda pela disciplina legal geral das Comissões de Ética para a Saúde
Member
|
Universidade de Lisboa Faculdade de Farmácia, Portugal |
Distinctions
Award
| 2017 | Best oral communication at 51ª Reunião Científica da Sociedade Anatómica Portuguesa (SAP)
Sopciedade Anatómica Portuguesa, Portugal
|
| 2013 | 1st Place in Poster Award Nano-Toxicology:Viability and cytotoxicity assays of novel anti-neoplasic nanoparticle formulations
for peritonea
BioNanoMed, Austria, Austria
|
| 2010 | 1st Place on the student poster competition on A new Drug Delivery System for an ophtalmic anti-VEGFsystem
The European Federation for Pharmaceutical Sciences, Sweden
|